Effectiveness of Homoeopathic medicines in management of Polycystic Ovarian Syndrome

Effectiveness of Homoeopathic medicines in management of Polycystic Ovarian Syndrome with elevated Homeostatic Model Assessment â??Insulin Resistance (HOMA-IR) value

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/03/040828

Enrollment

Registered

2022-03-04

Start date

Unknown

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Homoeopathic Medicine: Medicines will be selected as per homoeopathic protocol, after complete case taking. Medicines will be administered through oral route. Medicines will be administ

Duration Of Therapy- 1 Year Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed case of PCOS as per Rotterdam criteria PCOS cases with elevated HOMA IR value Patients who have signed informed consent

Exclusion criteria

Exclusion criteria: Cases with cushings syndrome Adrenal adenoma and ovarian tumours Pregnant and lactating mothers. Clinical history of cancer, Cardiovascular disease and HIV. Type 2 diabetes patient under Metformin

Design outcomes

Primary

Measure	Time frame
To find out the effectiveness of Homoeopathic Medicines on elevated HOMA â??IR value in Polycystic ovarian syndrome.Timepoint: 1 YEAR	—

Secondary

Measure	Time frame
1) To determine the effectiveness of Homoeopathic medicines in reduction of ovarian volume using USG findings. 2) To evaluate the effects of Homoeopathic medicine on Testosterone levels in cases with PCOS. 3) To find out the quality of life of women having polycystic ovarian syndromeTimepoint: 1 YEAR FOLLOW UP	—

Countries

India

Contacts

Public ContactDr R S Krishneswari

Kerala University of Health Sciences

krishneswarirs@gmail.com9445646864

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026